{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/nuvation-bio-granted-fda-fast-track-designation-for-safusidenib-for-treatment-of-idh1-mutant-glioma-302855678.html", "message": "News view counter 894239 successfully enlarged"}